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Invasion of extravillous trophoblast cell types into maternal uterine tissues is essential for successful
human placental development and progression of pregnancy. Whereas endovascular trophoblasts
migrate into the maternal spiral arteries, interstitial trophoblasts invade the decidual stroma, colonize
the vessels from outside and communicate with diverse uterine cell types such as decidual stromal cells,
macrophages and uterine NK cells. For example, interstitial trophoblasts expressing polymorphic human
leukocyte antigen-C interact with uterine NK cells through binding to their killer immunoglobulin-like
receptors which likely plays a role in trophoblast invasion and reproductive success of pregnancy.
Both extravillous trophoblast subtypes are critically involved in the vascular transformation of the spiral
arteries into dilated conduits ensuring appropriate blood ﬂow into the intervillous space. Failures in this
remodeling process are thought to be associated with severe forms of fetal growth restriction,
preeclampsia and other pregnancy complications warranting studies on the molecular regulation of
extravillous trophoblast differentiation. Moreover, interstitial trophoblast-derived hormones may regu-
late diverse biological functions in the decidua. In particular, human chorionic gonadotrophin has been
shown to promote angiogenesis and to suppress apoptosis of endometrial stromal cells. In return,
decidual cells produce a plethora of soluble factors controlling trophoblast invasion in a time- and
distance-dependent manner. However, the underlying mechanisms have not been fully elucidated. Here,
we will summarize autocrine as well as paracrine factors regulating invasion of extravillous trophoblasts
and discuss critical signaling cascades involved. In addition, we will focus on key regulatory transcription
factors controlling cell column proliferation and differentiation of the human extravillous trophoblast.
 2012 Published by IFPA and Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
1.1. General aspects
Development of placental extravillous trophoblasts (EVT)
migrating into maternal uterine tissue is fundamental to successful
placentation and fetal outcome. The trophoblast invasion process
starts early in pregnancy and continues until the 20th week of
gestation. Within the ﬁrst weeks endovascular trophoblasts
migrate into the maternal spiral arteries and plug those vessels,
likely to prevent precocious onset of maternal blood ﬂow into the
intervillous space [1]. Abnormal trophoblast invasion, incomplete
vessel occlusion and a premature rise in oxygen levels are thought
to damage the placental villi due to oxidative stress potentially
resulting in the development of early pregnancy complications
such as miscarriage [2].x: þ43 1 40400 7842.
t (M. Knöﬂer).
. Open access under CC BY-NC-ND liceLittle is known about the factors controlling trophoblast inva-
sion in early human gestation. However, it is likely that factors
secreted from endometrial glands such as epidermal growth factor
(EGF), vascular endothelial growth factor (vEGF), and various
cytokines controlling placental and embryonic growth during the
ﬁrst trimester are also critically involved in early trophoblast
differentiation processes [3]. Once the placenta switches from
histiotrophic to hemotrophic nutrition, trophoblast plugs are dis-
solved and extensive remodeling of the spiral arteries within the
decidual and the inner part of the myometrium takes place
involving both endovascular and interstitial trophoblasts, the latter
colonizing the arteries from outside [1]. The transformation process
is characterized by disruption of the vascular wall and elastolysis
and involves diverse coordinated interactions between vascular
smooth muscle cells, uterine natural killer cell (uNK) cells and
invasive trophoblasts [4]. Conversion of the vessels into dilated
conduits is thought to reduce contractility, pressure and rate of
blood ﬂow into the intervillous space supporting a constant
delivery of oxygen and nutrients to the developing fetus [2].nse.
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process are thought to be associated with the development of
gestational diseases such as severe forms of intrauterine growth
restriction and preeclampsia [5]. Fluctuations in oxygen concen-
trations could be an underlying cause since hypoxia and re-
oxygenation of placental tissue likely provokes stress-mediated
secretion of harmful cytokines into the maternal circulation,
which may result in endothelial dysfunction and the clinical
symptoms of preeclampsia such as elevated blood pressure [2].
Besides their role in spiral artery remodeling interstitial tropho-
blasts are known to interact with uNK cells upon binding of human
leukocyte antigen-C to maternal killer immunoglobulin-like
receptors, thereby likely modulating maternal immune responses
and, as a consequence, placental development [6]. Moreover,
invasive trophoblasts could provide chemotactic signals to uterine
leukocytes [4], and affect decidual angiogenesis and apoptosis by
secreting human chorionic gonadotrophin (hCG) [7]. Interstitial
trophoblasts may also aggregate and partly fuse to form placental
bed giant cells which is considered as the end-stage of extravillous
trophoblast differentiation [8]. The speciﬁc functions of giant cells,
however, as well as the molecular mechanisms triggering their
formation are mostly unknown. The two different differentiation
pathways of extravillous trophoblasts as well as their predominant
functions are summarized in Fig. 1.
1.2. Invasive differentiation program of the anchoring villus
Since blood ﬂow to the placenta has to be precisely regulated
throughout pregnancy, oxygen has been considered as a main
regulator of trophoblast proliferation and differentiation. High
oxygen levels promote invasion, whereas low oxygen causes
hypoxia-inducible factor 1a (HIF-1a)-dependent villous tropho-
blast proliferation in accordance with rapid growth of the placenta
in early pregnancy [9]. However, the role of oxygen remains
controversial since it cannot explain early endovascular trophoblast
invasion and plugging of spiral arteries which in early pregnancy
may occur in the absence of blood ﬂow and oxygen [1]. Along thoseFig. 1. Development of different extravillous trophoblast subtypes and their functions.
Progenitors residing at the basement membrane of cell columns (cell column
trophoblast, CCT) give rise to interstitial cytotrophoblasts (iCTB) invading the uterine
decidua and endovascular cytotrophoblasts (eCTB) migrating into the maternal spiral
arteries.lines, increased invasiveness of trophoblasts under hypoxia has also
been reported by different authors [10]. In addition, oxygen
concentrations as well as diffusion distance in vitro are still under
discussion [11].
Cultivation of ﬁrst trimester villous explant cultures under 20%
oxygen induces matrix attachment, column formation and differ-
entiation even in the absence of serum [12] suggesting that
proliferation and invasion of EVT are triggered by an intrinsic
differentiation program. Correct integrin switching, a hallmark of
the differentiation process of the anchoring villus, takes places in
EVTmigrating on top of collagen I- or ﬁbronectin-coated surfaces or
upon invasion into Matrigel [13e15] suggesting that ECM compo-
sition is of minor importance for some key features of EVT differ-
entiation. Hence, besides oxygen concentrations numerous growth
factors released from trophoblasts and the villous stromal core,
such as IGF-I [16], likely control the endogenous differentiation
program of EVT. Along those lines, EVTs were shown to produce
a wide range of receptors for cytokines, chemokines, and growth
factors allowing for precise autocrine as well as paracrine control of
trophoblast invasion [17].
2. Soluble factors controlling trophoblast motility
2.1. Paracrine effectors of trophoblast invasion and migration
Timing and extent of interstitial trophoblast invasion is thought
to be controlled by a plethora of factors expressed in the diverse
decidual cells. Soluble proteins secreted from luminal and/or
glandular epithelia such as leukemia inhibitory factor (LIF), EGF,
interleukin-11 (IL-11), activins and chemokines which likely
promote blastocyst implantation are also expressed in different
decidual cell types. In summary, uNK cells, decidual stromal cells,
and macrophages produce growth factors, cytokines, interleukins,
chemokines, prostaglandins and angiogenic growth factors which
have been shown to regulate invasion and/or migration in different
in vitro trophoblast model systems (Fig. 2). Moreover, each decidual
cell type secretes factors promoting and inhibiting trophoblast
motility. Whereas the role of individual factors in trophoblast
invasion has been studied, the combinatorial effects of proteins as
well as their concentrations at different gestational times remain
largely unknown. Along those lines, the overall role of the decidua
in trophoblast invasion is still a matter of discussion. Since
trophoblast invasion does not occur beyond the upper part of the
myometrium, the decidua is generally considered as an inhibitory
tissue restraining and limiting trophoblast invasiveness. Recent
in vitro experiments, however, suggest that decidual supernatants
and cultures may actually increase trophoblast invasion. Whether
this effect is due to the utilization of tumorigenic and immortalized
trophoblasts in these studies, however, remains to be determined
[18e20].
2.2. Autocrine factors regulating trophoblast invasion and
migration
The occurrence of tubal pregnancies suggests that EVT exhibit
a strongly activating, intrinsic differentiation program promoting
cell invasion independently of the local environment. Similar to
tumor cells, invasive EVTare equippedwith different growth factor-
dependent protease systems, i.e. matrix metalloproteinases
(MMPs), and urokinase plasminogen activator (uPA) allowing for
ECM degradation within the decidua [21e23]. Autocrine factors
such as insulin-like growth factor-II (IGF-II), hyperglycosylated hCG
(h-hCG), heparin-binding epidermal growth factor (HB-EGF),
interleukins and others (Fig. 3) were shown to increase expression
and activity of EVT-derived proteases of which the gelatinases
Fig. 2. The inﬂuence of decidual cell types on interstitial trophoblast invasion and migration. Predominant cell types of the maternal decidua, uterine natural killer (uNK) cells,
decidual stromal cells (DSC) and decidual macrophages produce soluble factors promoting and inhibiting trophoblast motility.
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a considerable overlap in expression patterns of soluble factors
secreted from EVT and the decidual cell types, it may not be
surprising that many of the paracrine factors depicted in Fig. 2 also
activate these protease systems. Both decidua and EVT, however,
also produce the respective inhibitors, tissue inhibitors of metal-
loproteinases (TIMPs) and plasminogen activator inhibitors (PAIs)
likely to ﬁne-tune and limit trophoblast invasiveness [24]. Indeed,
decidual (Fig. 2) as well as EVT-derived (Fig. 3) factors such as
transforming growth factors (TGFs), Nodal, or tumour necrosis
factor a (TNFa) were shown to elevate TIMP or PAI expression
[24e26]. Besides degradation of ECM components invasive
trophoblasts speciﬁcally express different integrins, for example
a5b1 and a1b1 heterodimers known to promote trophoblast
adhesion and migration by interacting with ﬁbronectin and
collagen/laminin, respectively [13].
2.3. Signalling cascades involved in trophoblast motility
Signaling pathways known to regulate growth and motility in
other cellular systems also play fundamental roles in EVT.
Whereas the speciﬁc effects of growth factors and sequential steps
of signaling transduction cascades controlling trophoblast prolif-
eration and invasion/migration were discussed in the past [22,27],
we here brieﬂy summarize the motility-promoting pathways
which have been functionally evaluated by using chemical inhib-
itors, antisense oligonucleotides or siRNA-mediated gene silencing
of critical signaling components (Fig. 4). As also recently
mentioned [22] inhibition of the MAPK kinase (MEK)/extracellular
regulated kinase (ERK) pathway or phosphoinositide 3-kinase(PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling
affected hCG, EGF, IGF-II and hepatocyte growth factor (HGF)-
dependent migration and invasion suggesting that these factors
act through several cascades in EVT. Other proteins such as IGF-I
and insulin-like growth factor binding protein-1 (IGFBP-1) may
increase trophoblast migration through focal adhesion kinase
(FAK) and integrin-linked kinase (ILK) activation since down-
regulation of the kinases was shown to reduce stimulus-
dependent trophoblast motility. Along those lines, gene silencing
of components of the Rho-ROCK pathway, Rho, Rac1, CDC42 and
ROCK also negatively affected prostaglandin E2 (PGE2) and IGF-II-
dependent trophoblast migration. Leptin and IL-11 were shown to
signal through Janus kinase (JAK)/Signal Transducer and Activator
of Transcription (STAT) and silencing of STAT3 reduced trophoblast
invasion. Moreover, cascades involved in developmental processes
may also play critical roles in EVT differentiation. Wingless (Wnt)
induces trophoblast motility through PI3K/AKT signaling as well as
through the canonical Wnt pathway involving glycogen synthase
kinase-3b (GSK-3b)-dependent stabilization of b-catenin and
formation of nuclear, transcriptionally active T-cell factor-4 (TCF-
4)/b-catenin complexes [28e30]. In addition, Notch signaling
provoking generation of Notch intracellular domain (NICD) which
acts as a co-activator of the transcription factor RBPJk could be
involved in endovascular trophoblast invasion [31]. Kinases known
to promote trophoblast invasion might be negatively affected by
inhibitory molecules present in EVT and/or decidua. For example
endostatin, the C-terminal cleavage product of collagen XVIII is
expressed in decidual stromal cells [32] and impairs IGF-II-
mediated trophoblast migration by downregulating AKT/mTOR
activity [15]. Endostatin is likely generated by EVT-derived
Fig. 3. Autocrine factors secreted from EVT promoting and inhibiting trophoblast
motility.
Fig. 4. Signaling pathways promoting trophoblast invasion and migration. Numerous
soluble growth factors expressed at the fetal-maternal interface signal through
receptor tyrosine kinases (RTK) and G-protein-coupled receptors (GPCR) to provoke
activation of MEK/ERK, PI3K/AKT/mTOR and Rho/ROCK signaling. Besides the JAK/STAT
pathway downstream of cytokine receptor family 1 (CRF1), Wnt-dependent activation
of frizzled (Fzd) receptors as well as Notch activation could be involved in controlling
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invasiveness [33].trophoblast motility.3. Cell column formation and EVT differentiation
EVT differentiation in anchoring villi is characterized by tran-
sient proliferation in proximal areas of the cell column, cell cycle
exit at more distal sites, loss of cell-cell contacts and local invasion
into decidual stromal compartments. Therefore, it is likely that
a complex network of key nuclear factors regulates maintenance of
cell column progenitors, growth and stability of the column as well
as development of distinct EVT subtypes. Little, however, is known
about the transcription factors controlling commitment and
differentiation of interstitial or endovascular trophoblasts. Simi-
larly, upstream signaling pathways activating these factors as well
as their putative target genes remain largely elusive.3.1. Regulatory transcription factors controlling cell column
proliferation and EVT differentiation
Many different nuclear factors were shown to be expressed in
cell columns and/or EVT [34,35], and changes in gestational
diseases such as fetal growth restriction were noticed [36].
However, few of them have been functionally analyzed. Regulatory
transcription factors could be divided into two classes, proteins
that are differentially expressed between proliferative cell column
trophoblasts (CCT) and non-growing EVT, and proteins that are
uniformly expressed. Since the latter also display distinct func-
tions in CCT and EVT, it is likely that their activity is differentially
regulated by post-translational modiﬁcations and/or co-activator
recruitment. The expression patterns of transcription factors
which have been functionally tested in different trophoblast
model systems as well as their roles in EVT differentiation are
depicted in Fig. 5. H2.0-like homeobox (HLX), HIF-1a, and the
winged helix protein Storkhead box 1 (Stox1) promoted tropho-
blast proliferation, and gene silencing of HIF-1a and Stox1
increased trophoblast invasion suggesting an inhibitory role of thetwo factors in EVT differentiation [9,36,37]. Both HIF-1a and Stox1
could be involved in the pathogenesis of preeclampsia. TGFb3, an
inhibitor of EVT differentiation controlled by HIF-1a, was shown to
be elevated in placentae of women suffering from this particular
disorder [9]. Downregulation of TGFb3 restored the invasive
capacity of preeclamptic villi in vitro suggesting that correct
oxygen sensing via HIF-1a could be affected in the gestational
disease. Stox1, on the other hand, has been identiﬁed as
a susceptibility gene for familial preeclampsia in a Dutch pop-
ulation [37]. The identiﬁed mutation in Stox1, Y153H, may increase
binding activity of the factor to target genes such as aT-catenin
and thereby maintain trophoblast adhesion and proliferation
instead of promoting EVT differentiation. Similarly, inhibitor of
DNA binding 2 (Id2) was shown to act as a negative regulator of
trophoblast invasiveness [38]. Downregulation of its expression
during differentiation likely provokes elevated activities of
differentiation-promoting basic helix-loop-helix (bHLH) genes in
EVTs [39]. Similarly, ligand-dependent activation of proliferator-
activated receptor g (PPARg), controlling invasion-promoting
genes such as hCG, interferes with trophoblast motility [40]. In
contrast, glial cells missing 1 (GCM1) and TCF-4 are induced in
non-proliferating EVT and stimulate trophoblast migration and
invasion [28,41]. Nuclear localization of the co-activator of TCF-4,
b-catenin, was observed in a subset of EVT and complete hydati-
diform mole placentae displayed elevated expression of the
protein suggesting abnormal Wnt signaling in these tissues [28].
Besides GCM1 and TCF-4, siRNA-mediated downregulation of an
isoform of Ikaros (Ikx), of STAT3 and of EGF-induced activating
protein-2a (AP-2a) also diminished trophoblast motility [42e44].
With respect to downstream effects of these factors, MMPs and
uPA could be the prime target genes. Indeed, EGF/AP-2a and Wnt/
TCF were shown to induce uPA and/or MMP-2 expression in EVT
[29,42].
Fig. 5. Expression patterns and roles of regulatory transcription factors in EVT differentiation. Cell column trophoblasts (CCT) and extravillous trophoblasts (EVT) produce activators
as well as inhibitors of trophoblast proliferation and invasion. Factors such as GCM1 and TCF-4 are absent from CCT progenitors and proliferative CCTs, respectively, corroborating
their positive functions in EVT differentiation and invasion.
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Trophoblast invasion and migration are controlled by
a complex network of soluble autocrine and paracrine factors,
signaling pathways and regulatory transcription factors. Besides
the endogenous differentiation program of the anchoring villus
promoting local invasion, maternal decidual cell types, i.e.
decidual stromal cells, macrophages and uterine NK cells modu-
late trophoblast invasiveness. Despite the fact that an increasing
number of regulatory factors are being unraveled, combinatorial
effects, gestation-dependent changes of the regulatory network aswell as the mechanisms controlling depth and timing of tropho-
blast invasion remain largely elusive. Along those lines, numerous
unsolved questions and controversial views exist in the literature
which should be answered in the future using appropriate
trophoblast model systems and experimental approaches (Fig. 6).
It is hoped that a better understanding of the molecular processes
regulating EVT differentiation and invasion will improve our
understanding about the role of the placenta in gestational
diseases such as intrauterine growth restriction, preeclampsia and
other pregnancy complications with incomplete spiral artery
remodeling.
Fig. 6. Open questions concerning regulatory mechanisms controlling human EVT differentiation and invasion. References indicate additional review articles and original publi-
cations where the respective research problem has been brought up, discussed or recently tackled.
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